82 SQ3370 is a novel approach that decreases adverse drug exposure and achieves robust injected and non-injected anti-tumor responses

• Kui Wu,
• Amir Mahmoodi,
• Michael Zakharian,
• Maksim Royzen

Affiliations

Kui Wu

2University at Albany, Albany, NY, USA

Amir Mahmoodi

1Shasqi, Inc., San Francisco, CA, USA

Michael Zakharian

1Shasqi, Inc., San Francisco, CA, USA

Maksim Royzen

2University at Albany, Albany, NY, USA